Blog

LifeSci Advisors — Daily Market Digest — Friday, September 30, 2016

BioShares Biotechnology Clinical Trials (BBC): $22.20, -$0.99, -23.6% YTD BioShares Biotechnology Products (BBP): $32.75, -$1.04, +6.3% YTD     MARKET COMMENTARY   Weak economic data from China and Japan coupled with lower oil prices a day after OPEC members agreed to reduce output, weighed […]

By |September 30th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Thursday, September 29, 2016

BioShares Biotechnology Clinical Trials (BBC): $23.19, -$.013, -20.2% YTD BioShares Biotechnology Products (BBP): $33.79, -$0.40, +9.6% YTD     MARKET COMMENTARY   U.S. stock index futures inched lower, amidst a surprise output cut agreement by the Organization of the Petroleum Exporting Countries, as investors […]

By |September 29th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Wednesday, September 28, 2016

BioShares Biotechnology Clinical Trials (BBC): $23.32, +$0.43, -19.7% YTD BioShares Biotechnology Products (BBP): $34.19, +$0.22, +10.9% YTD     MARKET COMMENTARY   U.S. stock index futures were little changed ahead of a testimony by the U.S. Federal Reserve Chair Janet Yellen before a Congressional […]

By |September 28th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Tuesday, September 27, 2016

BioShares Biotechnology Clinical Trials (BBC): $22.89, -$0.16, -21.2% YTD BioShares Biotechnology Products (BBP): $33.97, -$0.41, +10.2% YTD     MARKET COMMENTARY   Following the first U.S. presidential debate where investors awarded the debate to Democrat Hillary Clinton over Republican Donald Trump, U.S. stock index […]

By |September 27th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Monday, September 26, 2016

BioShares Biotechnology Clinical Trials (BBC): $23.05, -$0.07, -20.7% YTD BioShares Biotechnology Products (BBP): $34.38, -$0.24, +11.6% YTD     MARKET COMMENTARY   U.S. stock index futures retreated as investors waited to see how Republican Donald Trump and Democratic Hillary Clinton would fare in the […]

By |September 26th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Friday, September 23, 2016

BioShares Biotechnology Clinical Trials (BBC): $23.12, +$0.24, -20.4% YTD BioShares Biotechnology Products (BBP): $34.62, +$0.44, +12.3% YTD     MARKET COMMENTARY   U.S. stock index futures edged lower a day after the S&P enjoyed its biggest 2-day rally in 2 months following the U.S. […]

By |September 23rd, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Thursday, September 22, 2016

BioShares Biotechnology Clinical Trials (BBC): $22.88, +$0.15 BioShares Biotechnology Products (BBP): $34.18, +$0.50     MARKET COMMENTARY   World shares, commodities and bonds rallied, while the dollar weakened after the U.S. Federal Reserve left interest rates unchanged and projected a less aggressive rise in […]

By |September 22nd, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Wednesday, September 21, 2016

BioShares Biotechnology Clinical Trials (BBC): $22.73, +$0.48, -21.8% YTD BioShares Biotechnology Products (BBP): $33.68, +$0.64, +9.3% YTD     MARKET COMMENTARY   Global stocks advanced, led by a surge in bank shares, after the Bank of Japan surprised markets by adopting a target for […]

By |September 21st, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Tuesday, September 20, 2016

BioShares Biotechnology Clinical Trials (BBC): $22.25, +$0.48, -23.4% YTD BioShares Biotechnology Products (BBP): $33.04, +$0.03, +7.2% YTD     MARKET COMMENTARY   U.S. stock index futures edged higher as investors await comments from Federal Reserve Chair Janet Yellen, due tomorrow, for clues about the […]

By |September 20th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Monday, September 19, 2016

By |September 19th, 2016|Daily Digest|Comments Off

Daily Market Digest — Thursday, September 15, 2016

BioShares Biotechnology Clinical Trials (BBC): $21.39, +$0.78, -26.4% YTD
BioShares Biotechnology Products (BBP): $32.15, +$0.62, +4.3% YTD

 

MARKET COMMENTARY
Wall Street was set to open higher as investors await a flurry of economic data including retail sales, industrial production, producer price index, business inventories and weekly jobless claims. European markets were trading modestly higher, while Asian stock […]

By |September 15th, 2016|Daily Digest|Comments Off

Daily Market Digest — Thursday, September 15, 2016

BioShares Biotechnology Clinical Trials (BBC): $21.39, +$0.78, -26.4% YTD
BioShares Biotechnology Products (BBP): $32.15, +$0.62, +4.3% YTD
 
MARKET COMMENTARY
 
Wall Street was set to open higher as investors await a flurry of economic data including retail sales, industrial production, producer price index, business inventories and weekly jobless claims. European markets were trading modestly higher, while Asian stock […]

By |September 15th, 2016|Daily Digest|Comments Off

Daily Market Digest — Wednesday, September 14, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.61, -$0.20, -29.1% YTD BioShares Biotechnology Products (BBP): $31.53, -$0.27, +2.3% YTD     MARKET COMMENTARY   U.S. stock index futures were little changed as concerns over rising bond yields kept investors in a broadly risk-averse mode. […]

By |September 14th, 2016|Daily Digest|Comments Off

Daily Market Digest — Tuesday, September 13, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.81, +$0.31, -28.4% YTD

BioShares Biotechnology Products (BBP): $31.80, +$0.85, +3.2% YTD

 

MARKET COMMENTARY

U.S. stock index futures dipped despite comments from dovish Federal Reserve Governor Lael Brainard, which cautioned against removing support for the U.S. economy too quickly. The Treasury department is expected to release the Federal budget for August. European […]

By |September 13th, 2016|Daily Digest|Comments Off

Daily Market Digest — Tuesday, August 30, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.19, +$0.14, -30.5% YTD BioShares Biotechnology Products (BBP): $30.59, -$0.13, -0.7% YTD     MARKET COMMENTARY   U.S. stock index futures were mostly flat as attention turned to U.S. payrolls data, expected later this week, for further clues on […]

By |September 1st, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Thursday, September 1, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.02, -$0.44, -31.1% YTD
BioShares Biotechnology Products (BBP): $30.22, -$0.32, -1.9% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures pointed to a higher open ahead of a flurry of economic data releases later in the day. Jobless claims, Markit and ISM manufacturing index and vehicle sales data are on the economic
calendar, and […]

By |September 1st, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Wednesday, August 31, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.36, +$0.19, -29.9% YTD
BioShares Biotechnology Products (BBP): $30.54, -$0.05, -0.9% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures traded flat ahead of economic data releases, including ADP national employment, Chicago PMI, and pending home sales index which occupy the day’s economic calendar. Salesforce.com
is scheduled to report after the closing bell. Asian […]

By |August 31st, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Tuesday, August 30, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.19, +$0.14, -30.5% YTD
BioShares Biotechnology Products (BBP): $30.59, -$0.13, -0.7% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures were mostly flat as attention turned to U.S. payrolls data, expected later this week, for further clues on the pace of rate hikes by the Federal Reserve. A busy economic calendar
comprises consumer confidence […]

By |August 30th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Monday, August 29, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.05, +$0.26, -31.0% YTD
BioShares Biotechnology Products (BBP): $30.72, +$0.35, -0.3% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures were little changed after hawkish comments from Federal Reserve Chair Janet Yellen left the door open to a U.S. interest rate hike as early as next month. Data from the U.S.
Commerce Department is […]

By |August 29th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Friday, August 26, 2016

BioShares Biotechnology Clinical Trials (BBC):  $19.79, -$0.30, -31.9% YTD
BioShares Biotechnology Products (BBP): $30.37, -$0.17, -1.5% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures struggled for direction ahead of a keynote speech by U.S. Federal Reserve Chair Janet Yellen. Investors also keenly awaited growth figures, U-Mich sentiment data, and corporate
profits for the second quarter to help gauge […]

By |August 26th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Thursday, August 25, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.09, -$1.04, -30.8% YTD
BioShares Biotechnology Products (BBP): $30.54, -$1.04, -0.9% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures and the dollar weakened as investors took to sidelines ahead of a speech by Federal Reserve Chair Janet Yellen at a global central bankers’ meeting in Jackson Hole. July durable
goods and August Markit […]

By |August 25th, 2016|Daily Digest|Comments Off

Daily Market Digest — Wednesday, August 24, 2016

BioShares Biotechnology Clinical Trials (BBC): $21.13, +$0.12
BioShares Biotechnology Products (BBP): $31.58, +$0.03
 
 
MARKET COMMENTARY
 
U.S. stock index futures were little changed as the main focus remained on the global central banks meet at Jackson Hole this week where U.S. Federal Reserve Chair Janet Yellen might provide clues on
a possible interest rate hike. Building permits, monthly […]

By |August 24th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Tuesday, August 23, 2016

BioShares Biotechnology Clinical Trials (BBC): $21.01, +$0.57, -27.7% YTD
BioShares Biotechnology Products (BBP): $31.55, +$0.77, +2.4% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures pointed to a higher open, while the dollar was broadly weaker ahead of comments from Federal Reserve Chair Janet Yellen at the central bank’s annual meeting in Jackson Hole
later in the week. On […]

By |August 23rd, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Monday, August 22, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.44, -$0.17, -29.6% YTD
BioShares Biotechnology Products (BBP): $30.78, -$0.17, -0.2% YTD
 
 
MARKET COMMENTARY
 
Wall Street was set to start lower as investors geared up for central bankers’ annual meeting in Jackson Hole later in the week, with Fed Chair Janet Yellen due to speak the following day. Investors
expect the Federal […]

By |August 22nd, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Friday, August 19, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.61, +$0.16, -29.1% YTD
BioShares Biotechnology Products (BBP): $30.95, +$0.19, +0.4% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures pointed to a lower open as uncertainty brewed amongst investors regarding the U.S. Federal Reserve’s likelihood of raising interest rates this year. Market participants look
forward to Fed Chair Janet Yellen’s comments at the […]

By |August 19th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Thursday, August 18, 2016

BioShares Biotechnology Clinical Trials (BBC): $20.45, -$0.23, -29.6% YTD
BioShares Biotechnology Products (BBP): $30.76, +$0.03, -0.02% YTD
 
 
MARKET COMMENTARY
 
U.S. stock index futures were little changed after minutes of the U.S. Federal Reserve’s latest meeting showed policymakers were divided over whether to raise interest rates soon. Applied Materials
and Gap Inc are expected to report results after […]

By |August 18th, 2016|Daily Digest|Comments Off

LifeSci Advisors — Daily Market Digest — Wednesday, August 17, 2016

Myeloid NGS-based
panel for myeloid malignancies including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN).
 
Cytokinetics announced the completion of patient enrollment in VITALITY-ALS (Ventilatory Investigation
of Tirasemtiv and Assessment of Longitudinal Indices after Treatment for a Year in ALS), an international Phase III clinical trial of tirasemtiv in patients with ALS. […]

By |August 17th, 2016|Daily Digest|Comments Off